Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/23941
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-01-10T05:35:32Z | - |
dc.date.available | 2022-01-10T05:35:32Z | - |
dc.date.issued | 2001-09 | - |
dc.identifier.citation | İşbil, B. N. vd. (2001). "A central link between angiotensinergic and cholinergic systems; role of vasopressin". Peptides, 22(9), 1415-1420. | en_US |
dc.identifier.issn | 0196-9781 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0196978101004788 | - |
dc.identifier.uri | https://doi.org/10.1016/S0196-9781(01)00478-8 | - |
dc.identifier.uri | http://hdl.handle.net/11452/23941 | - |
dc.description.abstract | Participation of central cholinergic system in the effects of intracerebroventricular (i.c.v.) injection of angiotensin II (Ana II) on blood pressure and heart rate was studied in conscious, freely moving rats, Ang II dose-dependently increased blood pressure and decreased heart rate. Both atropine and mecamylamine (i.c.v.) pretreatments prevented the cardiovascular effects of Ana II. Pretreatment with a vasopressin V-1 antagonist also prevented the cardiovascular responses to Ang II. Our data suggest that the central pressor effect of Ang II is mediated in part by central acetylcholine via both muscarinic and nicotinic receptors, and vasopressin participates in this effect through V-1 receptors. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cholinergic system | en_US |
dc.subject | Ang II | en_US |
dc.subject | Blood pressure | en_US |
dc.subject | Heart rate | en_US |
dc.subject | Intracerebroventricular | en_US |
dc.subject | V1 antagonist | en_US |
dc.subject | Pressor | en_US |
dc.subject | Responses | en_US |
dc.subject | Release | en_US |
dc.subject | Injection | en_US |
dc.subject | Carbachol | en_US |
dc.subject | Drinking | en_US |
dc.subject | Brain | en_US |
dc.subject | Biochemistry & molecular biology | en_US |
dc.subject | Endocrinology & metabolism | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject.mesh | Angiotensin II | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Sympathetic nervous system | en_US |
dc.subject.mesh | Brain | en_US |
dc.subject.mesh | Receptors, vasopressin | en_US |
dc.subject.mesh | Atropine | tr_TR |
dc.subject.mesh | Blood pressure | tr_TR |
dc.subject.mesh | Consciousness | tr_TR |
dc.subject.mesh | Dose-response relationship, drug | tr_TR |
dc.subject.mesh | Drug Interactions | en_US |
dc.subject.mesh | Time factors | en_US |
dc.subject.mesh | Heart rate | en_US |
dc.subject.mesh | Injections, intraventricular | en_US |
dc.subject.mesh | Injections, intra-arterial | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mecamylamine | en_US |
dc.subject.mesh | Muscarinic antagonists | en_US |
dc.subject.mesh | Nicotinic antagonists | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, sprague-dawley | en_US |
dc.subject.mesh | Receptors, mmuscarinic | en_US |
dc.subject.mesh | Receptors, nicotinic | en_US |
dc.subject.mesh | Vasopressins | en_US |
dc.title | A central link between angiotensinergic and cholinergic systems; role of vasopressin | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000170561200008 | tr_TR |
dc.identifier.scopus | 2-s2.0-0034888525 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Fizyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0003-0863-1547 | tr_TR |
dc.identifier.startpage | 1415 | tr_TR |
dc.identifier.endpage | 1420 | tr_TR |
dc.identifier.volume | 22 | tr_TR |
dc.identifier.issue | 9 | tr_TR |
dc.relation.journal | Peptides | en_US |
dc.contributor.buuauthor | İşbil, Büyükcoşkun Naciye | - |
dc.contributor.buuauthor | Güleç, Güliz Uyar | - |
dc.contributor.buuauthor | Özlük, Kasım | - |
dc.contributor.researcherid | AAH-1692-2021 | tr_TR |
dc.contributor.researcherid | C-5730-2015 | tr_TR |
dc.identifier.pubmed | 11514022 | tr_TR |
dc.subject.wos | Biochemistry & molecular biology | en_US |
dc.subject.wos | Endocrinology & metabolism | en_US |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q2 (Biochemistry & molecular biology) | en_US |
dc.wos.quartile | Q2 (Pharmacology & pharmacy) | en_US |
dc.contributor.scopusid | 6603128152 | tr_TR |
dc.contributor.scopusid | 6602752303 | tr_TR |
dc.contributor.scopusid | 6602676331 | tr_TR |
dc.subject.scopus | Pregnanolone; Orexins; Scotophase | en_US |
dc.subject.emtree | Acetylcholine | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Cardiovascular effect | en_US |
dc.subject.emtree | Cardiovascular response | en_US |
dc.subject.emtree | Cholinergic system | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Blood pressure | en_US |
dc.subject.emtree | Dose response | en_US |
dc.subject.emtree | Heart rate | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Rat | en_US |
dc.subject.emtree | Angiotensin | en_US |
dc.subject.emtree | Atropine | en_US |
dc.subject.emtree | Mecamylamine | en_US |
dc.subject.emtree | Muscarinic receptor | en_US |
dc.subject.emtree | Nicotinic receptor | en_US |
dc.subject.emtree | Vasopressin | en_US |
dc.subject.emtree | Vasopressin receptor antagonist | en_US |
dc.subject.emtree | Vasopressin V1 receptor | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.